Search

everythinglearnresearchcommunity

for

Search:↓

Male cells need DHT to respond to testosterone, while female cells do not.

Red light exposure can slow aging in mice by improving fat metabolism.

Neurosteroids help protect fetal brains from asphyxia damage.

Hydroxytyrosol may help treat hair loss by reducing inflammation and oxidative stress.

Astilbin can potentially calm overactive immune responses, like in Type 1 Diabetes, by suppressing certain cell activities and reducing inflammation.

Neurosteroids in the brain can increase or decrease seizure risk in mice.

Dihydrotestosterone and 5α-Reductase play a role in hair loss and prostate health, and finasteride can increase hair growth in men without affecting sperm production, but it doesn't work for postmenopausal women with hair loss.

Progesterone and allopregnanolone increase glycine release in rat brain cells.

The discovery of 5α-reductase deficiency in guevedoces led to the development of important urologic medications.

5-Alpha Reductase Inhibitors are effective for male hair loss and some skin conditions, but their effectiveness in women and safety concerns require careful use.

PCAT1 and HOTAIR levels are lower in people with androgenic alopecia.

Low dose finasteride decreases certain steroids, possibly increasing depression risk.

Certain genetic variants reduce enzyme activity, contributing to non-classic congenital adrenal hyperplasia.

Reduced androgens linked to kinky hair disorder and hair loss; 5a-reductase inhibitors may help.

Tectona grandis leaf extracts, especially with propylene glycol, may be promising for topical hair loss treatments.

Methylated gene parts may cause finasteride-resistance in some enlarged prostate patients.

Higher CRHR1 levels in AA patients lead to increased inflammation.

The Fas/FasL pathway may play a role in alopecia areata.

A more sensitive assay was developed to detect enzyme activity converting arginine to citrulline in hair follicles.

A new test more accurately detects citrulline in hair follicles and pilomatrixomas.

Modified steroidal inhibitors showed promise in treating hormone-dependent cancers.

Ischemic modified albumin could be a new indicator of oxidative stress in people with alopecia areata.

Low-dose naltrexone may help reduce redness in certain scalp conditions.

A new, less toxic and more efficient method to create the anti-baldness compound RU58841 was developed in 2014.

Cynanchi Wilfordii Radix has strong antioxidant effects and may help treat male hair loss.

Alopecia areata patients show increased inflammation and OX40 activation, suggesting a new treatment target.

5α-reductase inhibitors like finasteride and dutasteride effectively treat BPH by reducing DHT levels.

A higher testosterone/dihydrotestosterone ratio in PCOS patients may indicate worse metabolic health.